| |
 |
| |
AUDITED FINANCIAL RESULTS FOR THE HALF YEAR ENDED 30TH SEPT 2008
(Rs. In Lacs) |
| Particulars |
Quarter ended |
Quarter ended |
Half Year Ended |
Half Year Ended |
Year ended |
| 30th Sept 08 |
30th Sept 07 |
30th Sept 2008 |
30th Sept 2007 |
31st Mar 2008 |
1.
|
(a) |
(Net) Sales / Income from operations |
11,968 |
9,414 |
23,167 |
18,800 |
37,650 |
| |
(b) |
Other Operating Income |
|
|
|
|
|
| 2. |
Expenditure |
|
|
|
|
|
| |
(a) |
(Increase) / Decrease in stock in trade |
81 |
670 |
(23) |
(517) |
695 |
| |
(b) |
Consumption of raw materials. |
5,811 |
5,286 |
17,454 |
16,921 |
21,077 |
| |
(c) |
Purchase of Traded Goods |
2,190 |
612 |
5,944 |
2,132 |
3,443 |
| |
(d) |
Employees cost |
345 |
255 |
1,012 |
778 |
1,114 |
| |
(e) |
Depreciation |
341 |
266 |
1,004 |
785 |
1,104 |
| |
(f) |
Other expenditure |
1,796 |
1,336 |
4,956 |
4,113 |
5,648 |
| |
(g) |
Total Expenditure |
10,564 |
8,425 |
30,347 |
24,212 |
33,081 |
| 3. |
Profit from Operating before Other Income |
1,139 |
736 |
4,310 |
3,253 |
4,570 |
| 4. |
Other Income |
29 |
2 |
31 |
6 |
17 |
| 5. |
Profit before Interest & Exceptional Items |
1,567 |
1,137 |
3,203 |
2,523 |
4,587 |
| 6. |
Interest |
604 |
201 |
1,164 |
367 |
1,184 |
| 7. |
Profit after Interest but before Exceptional Items |
1,158 |
533 |
2,371 |
1,358 |
2,315 |
| 8. |
Exceptional Items |
- |
- |
- |
- |
- |
| 9. |
Profit from Ordinary Activities before Tax |
1,158 |
533 |
2,371 |
1,358 |
2,315 |
| 10. |
Tax Expenses (Includes) |
480 |
- |
- |
- |
- |
| |
Provision for Taxation |
414 |
|
|
|
|
| |
Provision for FBT |
- |
|
|
|
|
| |
Provision for Deffered Taxation |
68 |
|
|
|
|
| 11. |
Net profit from ordinary Activities after Tax |
676 |
533 |
2,371 |
1,358 |
2,315 |
| 12. |
Extraodinary Item (net of tax expenses ) |
- |
- |
- |
- |
- |
| 13. |
Net Profit for the period |
1,158 |
533 |
2,371 |
1,358 |
2,315 |
| 14. |
Paid-up Equity Share Capital of Rs.10/- each. |
1,171 |
1,171 |
1,171 |
1,171 |
1,171 |
| 15. |
Reserves & Surplus (excluding revaluation reserves) |
|
- |
- |
- |
- |
| 16. |
Basic E P S (in Rs.) |
4.29 |
2.16 |
8.91 |
6.29 |
10.07 |
| 17. |
Public Shareholding |
5766044 |
6113030 |
5766044 |
6113030 |
6045866 |
| |
Number of Shares |
49.25 |
52.21 |
49.25 |
52.21 |
51.64 |
| 18. |
Promoters & Promoter GroupShareholding** |
|
|
|
|
|
| |
(a) |
Pledged/Encumbered' |
|
|
|
|
|
| |
|
- Number of Shares |
|
|
|
|
|
| |
|
-Percentage of shares( as a percentage of the
total shareholding of promoter and promoter group) |
|
|
|
|
|
| |
|
'-Percentage of shares( as a percentage of total sharecapital of the Company) |
|
|
|
|
|
| |
(b) |
Non-encumbered |
|
|
|
|
|
| |
|
- Number of Shares |
|
|
|
|
|
| |
|
-Percentage of shares( as a percentage of total shareholding of promoter and promoter group) |
|
|
|
|
|
| |
|
-Percentage of shares( as a percentage of total sharecapital of the Company) |
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
| Notes : |
| 1. |
There were no pending complaints at the beginning of the Quarter. During the quarter three complaintswere received and redressed. There were no complaints pending at the end of the quarter. |
| 2. |
Company is operating as a Single Segment Company, engaged in pharmaceuticals business hence, the disclosure requirement as per AS - 17 'Segment Reporting' is not attracted. |
| 3. |
The figures of the previous periods have been regrouped and rearranged wherever necessary. |
| 4. |
The above results, reviewed by the Audit Committee, have been taken on record by the Board of Directors at their meeting held on |
| For and on behalf of the Board |
| FOR AARTI DRUGS LIMITED |
| Place : Mumbai |
Harshit M Savla |
| Date : 20th Oct, 2008 |
(Jt. Managing Director) |
|
| |
| |
|
|
| |
| |
 |
| |
|
|
